Endogenous EPCR/aPC-PARI signaling prevents inflammation-induced vascular leakage and lethality

Blood

Volumn 113, Issue 12, 2009, Pages 2859-2866

  Niessen, Frank ^a   Furlan Freguia, Christian ^a   Fernández, José A ^a   Mosnier, Laurent O ^a   Castellino, Francis J ^b   Weiler, Hartmut ^c   Rosen, Hugh ^a   Griffin, John H ^a   Ruf, Wolfram ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOCKING ANTIBODY; LIPOPOLYSACCHARIDE; PROTEINASE ACTIVATED RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL FUNCTION; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; GENETIC MODEL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 63849278353     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-192385     Document Type: Article

References (48)

1. Opal SM. The nexus between systemic inflammation and disordered coagulation in sepsis. J Endotoxin Res. 2004;10:125-129.
2. Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol. 2004;25:536-542.
3. Ruf W. Emerging roles of tissue factor in viral hemorrhagic fever. Trends Immunol. 2004;25: 461-464.
4. Taylor FB, Chang A, Esmon CT, et al. Protein C prevents the coagulopathic and lethal effects of escherichia coli infusion in the baboon. J Clin Invest. 1987;79:918-925.
5. Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood. 2001;97:1685-1688.
6. Taylor FB Jr, Chang A, Ruf W, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991; 33:127-134.
7. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344:759-762.
8. Pawlinski R, Pedersen B, Schabbauer G, et al. Role of tissue factor and protease activated receptors in a mouse model of endotoxemia. Blood. 2004;103:1342-1347.
9. Xu H, Ploplis VA, Castellino FJ. A coagulation factor VII deficiency protects against acute inflammatory responses in mice. J Pathol. 2006;210: 488-496.
10. Levi M, Dorffler-Melly J, Reitsma P, et al. Aggravation of endotoxin-induced disseminated intra-vascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood. 2003;101:4823-4827.
11. Ganopolsky JG, Castellino FJ. A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol. 2004;165:1433-1446.
12. Iwaki T, Cruz DT, Martin JA, Castellino FJ. Acardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse. Blood. 2005;105:2364-2371.
13. Zheng X, Li W, Song Y, et al. Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia. J Thromb Haemost. 2007;5:1394-1400.
14. Weiler H, Lindner V, Kerlin B, et al. Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol. 2001;21: 1531-1537.
15. Li W, Zheng X, Gu J, et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost. 2005;3:1351-1359.
16. Zheng X, Li W, Gu JM, et al. Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice. Blood. 2007;109:1003- 1009.
17. Taylor FB Jr, Chang ACK, Peer GT, et al. DEGR- factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood. 1991;78: 364-368.
18. Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003;290:238-247.
19. Warren BL, Eid A, Singer P, et al. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286:1869-1878.
20. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
21. Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A. 2001;98: 7742-7747.
22. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.
23. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003;9:338-342.
24. Han MH, Hwang SI, Roy DB, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008;451: 1076-1081.
25. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2006;109:3161-3172.
26. Riewald M, Ruf W. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J Biol Chem. 2005;280:19808-19814.
27. Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood. 2005;105:3178-3184.
28. Feistritzer C, Schuepbach RA, Mosnier LO, et al. Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J Biol Chem. 2006;281:20077-20084.
29. Bae JS, Yang L, Manithody C, Rezaie AR. The ligand occupancy of endothelial protein C receptor switches the PAR-1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood. 2007;110:3909-3916.
30. Bae JS, Yang L, Rezaie AR. Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells. J Thromb Haemost. 2008;6:954-961.
31. Bae JS, Yang L, Rezaie AR. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci U S A. 2007;104: 2867-2872. 32. Finigan JH, Dudek SM, Singleton PA, et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phos-phate receptor transactivation. J Biol Chem. 2005;280:17286-17293.
32. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204:2439-2448.
33. Kaneider NC, Leger AJ, Agarwal A, et al. 'Role reversal' for the receptor PARI in sepsis-induced vascular damage. Nat Immunol. 2007;8:1303-1312.
34. Camerer E, Cornelissen I, Kataoka H, et al. Roles of protease-activated receptors in a mouse model of endotoxemia. Blood. 2006;107:3912-3921.
35. Niessen F, Schaffner F, Furlan-Freguia C, et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature. 2008;109: 654-658.
36. Singleton PA, Moreno-Vinasco L, Sammani S, et al. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol. 2007;37:222-231.
37. Mosnier LO, Zampolli A, Kerschen EJ, et al. Hyper-antithrombotic, non-cytoprotective Glu149Ala-activated protein C mutant. Blood. 2009 Feb 24. [Epub ahead of print]
38. Damiano BP, Cheung WM, Santulli RJ, et al. Cardiovascular responses mediated by protease- activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther. 1999; 288:671-678.
39. Ishii I, Friedman B, Ye X, et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem. 2001;276:33697-33704.
40. Allende ML, Sasaki T, Kawai H, et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem. 2004;279: 52487-52492.
41. Castellino FJ, Liang Z, Volkir SP, et al. Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb Haemost. 2002;88:462-472.
42. Yano K, Liaw PC, Mullington JM, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203:1447-1458.
43. Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest. 2002;110:1703-1716.
44. Mosnier LO, Yang XV, Griffin JH. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions. J Biol Chem. 2007;282: 33022-33033.
45. Mizugishi K, YamashitaT, Olivera A, et al. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol. 2005;25: 11113-11121.
46. Li X, Stankovic M, Bonder CS, et al. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood. 2008;111:3489-3497.
47. Tauseef M, Kini V, Knezevic N, et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine- 1-phosphate receptor signaling in endothelial cells. Circ Res. 2008;103:1164-1172.
48. Liu Y, Wada R, YamashitaT, et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest. 2000;106:951-961.